Preview Mode Links will not work in preview mode
Welcome to the Empowered Patient Podcast with Karen Jagoda.  This show offers a glimpse into the latest innovations in applying generative AI, novel therapeutics and vaccines, and the evolving dynamics in the medical and healthcare landscape. One focus is on how providers, pharmaceutical companies, and payers are empowering patients.  In addition, conversations often focus on how technology is empowering providers, care facilities, pharmaceutical companies, and payers to improve patient outcomes and reduce friction across the healthcare landscape.  Popular Topics Include: Virtual and digital health Use of AI, ML, and robots for clinical and administrative purposes  Value-based healthcare  Precision and stratified medicine Next-generation immuno, cell, and gene therapies Vaccines for infectious diseases and oncology Biomarkers and diagnostics Rare diseases MedTech and medical devices Clinical trials  Population health Chronic conditions l Clinician and staff burnout Smart hospitals The audience includes life science leaders, researchers, medical professionals, patient advocates, digital health entrepreneurs, patients, caregivers, healthcare solution providers, students, journalists, and investors.

Mar 30, 2020

Greg Merril, CEO, Adaptive Phage Therapeutics describes useful viruses that host on and kill bacteria acting as nature's natural antibiotic.  Phage therapy actually predates antibiotics but recent research has enabled scientist to better identify which phage will have the desired impact on specific bacteria.  Greg talks about how modern phage therapy, drawing on a large collection of phage, might become the best way to treat recalcitrant, chronic infections where antibiotics have failed.  Greg's father Carl Merril spent the majority of his career at NIH working on basic research on phage beginning in the mid 1960s.

#phagetherapy #phage #antibiotics #viruses

APhage.com

Listen to the podcast here.

APhage